Effects of phosphodiesterase‐5 inhibitor sildenafil on esophageal secondary peristalsis: Studies with high‐resolution manometry

2020 ◽  
Author(s):  
Ming‐Wun Wong ◽  
Chih‐Hsun Yi ◽  
Tso‐Tsai Liu ◽  
Wei‐Yi Lei ◽  
Jui‐Sheng Hung ◽  
...  
Keyword(s):  
High Resolution ◽  
Phosphodiesterase 5 Inhibitor ◽  
High Resolution Manometry ◽  
Secondary Peristalsis ◽  
Phosphodiesterase 5

Tu1412 IMPACT OF INEFFECTIVE ESOPHAGEAL MOTILITY ON SECONDARY PERISTALSIS IN GERD: STUDIES WITH HIGH RESOLUTION MANOMETRY

2020 ◽  
Vol 158 (6) ◽  
pp. S-1095-S-1096
Author(s):  
Wei-Yi Lei ◽  
Jen-Hung Wang ◽  
Ming-Wun Wong ◽  
Chih-Hsun Yi ◽  
Tso-Tsai Liu ◽  
...  
Keyword(s):  
High Resolution ◽  
Esophageal Motility ◽  
High Resolution Manometry ◽  
Ineffective Esophageal Motility ◽  
Secondary Peristalsis

Functional Luminal Imaging Probe (FLIP) as an Adjunctive Modality in Evaluation of Esophageal Dysmotility

2021 ◽  
Vol 1 (3) ◽  
pp. 286-295
Author(s):  
Domenico A. Farina ◽  
Dustin A. Carlson
Keyword(s):  
High Resolution ◽  
Clinical Settings ◽  
Esophageal Dysmotility ◽  
Therapy Outcomes ◽  
Esophageal Diseases ◽  
Imaging Probe ◽  
High Resolution Manometry ◽  
Functional Luminal Imaging Probe ◽  
Secondary Peristalsis ◽  
Post Therapy

The Functional Luminal Imaging Probe (FLIP) has emerged as a valuable adjunctive tool in the evaluation of esophageal diseases. Using volumetric distension, FLIP can assess secondary peristalsis and detect esophageal abnormalities that may not be evaluated by high-resolution manometry (HRM). In certain clinical settings, FLIP may allow for deferral of HRM. In therapy for esophageal diseases, FLIP has demonstrated value for its real-time interpretation, which can be used intra-procedurally to tailor therapy and to predict post-therapy outcomes. The future of FLIP looks promising as surgeons and gastroenterologists place increasing emphasis on non-manometric data to diagnose esophageal motility disorders.

Udenafil – ein neuer Phosphodiesterase-5-Inhibitor (PDE-5-I) – zur Therapie der portalen Hypertonie. Eine offene Dosisfindungsstudie

2011 ◽  
Vol 49 (08) ◽  
Author(s):  
P Deibert ◽  
S Eggerking ◽  
L Kupcinskas ◽  
J Sumskiene ◽  
R Mohrbacher ◽  
...  
Keyword(s):  
Phosphodiesterase 5 Inhibitor ◽  
Phosphodiesterase 5
Sign in / Sign up

Export Citation Format

Share Document